Skip to content


BMC Complementary and Alternative Medicine

What do you think about BMC? Take part in

Open Access

P01.06. The effect of bee venom pharmacopuncture therapy in a neuropathic pain rat model

  • Y Kwon1 and
  • M Park2
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201212(Suppl 1):P6

Published: 12 June 2012


The purpose was to examine the effect of bee venom (BV) pharmacopuncture therapy with different concentrations on neuropathic pain in a rat model.


We performed BV pharmacopuncture therapy with different concentrations on neuropathic pain in a rat model on the 7th day after ligating the L5 nerve as suggested by Kim and Chung. Rats were divided into a control group (treated with normal saline), experimental group I (treated with constantly increased BV concentration, from 1.67×10-3mg/kg to 8.35×10-3mg/kg, total 3.22×10-2mg), and experimental group II (treated fixed high concentration, 3.58×10-3mg/kg, total 3.22×10-2mg). BV pharmacopuncture was injected to Huantiao (GB30) every other day for 18 days. To identify any therapeutic effect, foot withdrawal threshold to mechanical and thermal stimulation, nerve conduction velocity (NCV), and c-Fos immunological reactivity in the dorsal horn of the spinal cord were analyzed.


In the pain threshold and the c-Fos immunological reactivity test, experimental group II showed a better therapeutic effect than in experimental group I. In NCV testing, experimental group I showed a better therapeutic effect than experimental group II in the early stage of BV treatment. In the latter stage of BV treatment, however, therapeutic effect was similar in both groups.


BV pharmacopuncture therapy was effective in neuropathic pain. Under the same total amount of BV dose, treatments with constantly increasing BV concentration and fixed high concentration BV had similar effect.

Authors’ Affiliations

Wonkwang University Hospital


© Kwon and Park; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.